5 Best Prefered Stocks To Own Right Now

Over the past two months, mutual funds and hedge funds liquidated momentum stocks, triggering a self-reinforcing selloff. As a result, nearly every single biotech stock has been pushed aggressively lower.  When this happens mispricings occur.  Fund managers take profits even on stocks that have great fundamentals and huge upside.

So, given this sell off, which of those stocks present a great buying opportunity  We ran a screen that looks for the best biotech stocks with the most upside potential.

First, we look for companies with a market capitalization greater than $200 million.  For the second level of the screen, the companies must have more than three analysts covering the stock.  Third, there has to be more than three analysts that have a price target on the stock.  Finally, we want to find stocks that are trading at a huge discount to analyst consensus price targets.

In running this screen for the first of May, the following five stocks have hit our radar as potential home runs.  These stocks have an average analyst price target that is at least 200% higher than its current share price.

Top 10 Consumer Service Companies To Invest In 2015: Vista Gold Corp (VGZ)

Vista Gold Corp. (Vista), incorporated on November 28, 1983, is engaged in the evaluation, acquisition, exploration and advancement of gold exploration and potential development projects. The Company's holdings include the Mt. Todd gold project in Australia; the Guadalupe de los Reyes gold/silver project in Mexico; the Concordia gold project in Mexico; the Awak Mas gold project in Indonesia; the Long Valley gold project in California, and mining claims in Utah. On April 6, 2011, the Company announced the completion of the combination involving Midas Gold, Inc., Vista's wholly owned subsidiary, Vista Gold U.S. Inc. and its wholly owned subsidiary, Idaho Gold Resources, LLC., whereby each party contributed their respective gold assets in the Yellow Pine-Stibnite District in Idaho to a new Canadian private company named Midas Gold Corp. (Midas Gold). In October 2013, the Company announced that it has sold the Los Cardones gold project in Baja California Sur, Mexico, to the Invecture Group (Invecture) and RPG Structured Finance S.a r.l.

Mt. Todd Gold Project

The Company holds the Mt. Todd gold project through its wholly owned subsidiary, Vista Gold Australia Pty. Ltd. The project is located 56 kilometers by road northwest of Katherine, Northern Territory, Australia, and approximately 250 kilometers south of Darwin. On September 6, 2011, the Company announced the results of its mineral resource estimate for the Batman deposit at the Company�� Mt. Todd gold project in Northern Territory, Australia.

Guadalupe de los Reyes Gold/Silver Project

The Company�� Guadalupe de los Reyes project is located in the State of Sinaloa, in western Mexico, approximately halfway between the cities of Mazatlan and Culiacan. The property is held through 37 federal mining concessions totaling about 6,310.9 hectares. During the year ended December 31, 2011, the Company received the initial results of its Phase I surface sampling program completed at its Guadalupe de los Reye! s gold/silver project in Sinaloa, Mexico. In June 2011, it initiated the first phase of a two-phase exploration program. The initial results from Phase I confirmed the surface continuity of gold/silver bearing veins over a combined strike length of 14 kilometers. During October 2011, the Company received the permits for its planned drilling program at the Guadalupe de los Reyes gold/silver project, and drilling on a 12-hole core program had started.

Concordia Gold Project

The Concordia gold project is located 55 kilometers southeast of the city of La Paz, in the Mexican state of Baja California Sur. The project area covers over 3,710 hectares and is consists of 15 mining concessions. Vista holds the Concordia gold project through its wholly owned, Mexican subsidiary, Desarrollos Zapal, S.A. de C.V. (DZ Mexico). On February 7, 2012, the Company announced that the Company had entered into an Earn-in Right Agreement (the Earn-in Right Agreement) with Mexico-based Invecture Group, S.A. de C.V. (Invecture) with respect to Vista's Concordia gold project in Baja California Sur, Mexico.

Awak Mas Gold Project

The the Awak Mas gold project is held through its indirect wholly owned subsidiary, PT Masmindo Dwi. The Awak Mas property is situated on the southern side of the Central Sulawesi Metamorphic Belt within a 50-kilometer-long, north-northeast trending fault-bounded block of basement metamorphic rocks and younger sediments. On June 13, 2011, the Company�� wholly owned subsidiary, Vista Gold (Barbados) Corp. (Vista Barbados) entered into an additional option agreement (Additional Option Agreement) with Pan Asia Resources Corp. (Pan Asia). The Additional Option Agreement provides Pan Asia with the opportunity to earn an additional 20% interest in its Awak Mas gold project in Indonesia after it has earned a 60% interest in the project pursuant to the joint venture agreement between Vista Barbados and Pan Asia that was executed in December 2009. In September 20! 11, the A! dditional Option Agreement and JV Agreement were assigned from Pan Asia to Awak Mas Holdings Pty.

Long Valley Gold Project

The Long Valley gold project is located in the Inyo National Forest, about 7 miles east of the town of Mammoth Lakes, in Mono County, California. The property consists of 95 contiguous, unpatented mining claims that cover an area of approximately 1,963 acres. The Long Valley gold project is held through its indirect wholly owned subsidiary Vista Gold California LLC.

Advisors' Opinion:

• [By Bryan Murphy]

  A couple of days ago when gold and the SPDR Gold Trust ETF (NYSEARCA:GLD) were getting back into a bullish groove, I advocated Randgold Resources Ltd. ADR (NASDAQ:GOLD) as the better way to play gold's rebound. GOLD had fought its way back above a key ceiling, and was poised to take off... much more so than GLD was. To tell you the truth though, Randgold Resources Ltd. wasn't actually my first choice. The gold mining name I wanted to suggest was a little smaller - Vista Gold Corp. (NYSEMKT:VGZ). In the meantime, VGZ has forged out enough of the bullish progress I saw brewing then to merit a mention now.

5 Best Prefered Stocks To Own Right Now: Eutelsat Communications SA (ETL)

Eutelsat Communications SA is a France-based holding company that provides fixed satellite services. It provides four types of services, including broadcast services, such as direct-to-home and professional broadcasting; broadband services, comprising broadband Internet access; telecoms and data services to ensure permanent communications links from all points of the globe, establish or restore communications in an emergency and multicast content; as well as mobile and maritime communications, such as fleet management and on- and off-shore broadband maritime communications. It operates a fleet of satellites covering Europe, the Middle East, North and sub-Saharan Africa, as well as parts of Asia and the Americas. In January 2014, it acquired Satelites Mexicanos, S.A. de C.V. and together with SES SA have completed the sale to EchoStar Corp. of Solaris Mobile Ltd. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Eutelsat Communications SA (ETL) declined 6.2 percent to 21.02 euros after predicting sales will grow by more than 2.5 percent for the year 2013 to 2014. The company, which operates 31 satellites, forecast growth of more than 5 percent for the following two years through June 2016. JPMorgan Chase & Co. cut its price target for the stock to 24 euros from 33 euros, saying analysts��will probably reduce their estimates following the company�� revised guidance.

5 Best Prefered Stocks To Own Right Now: Momenta Pharmaceuticals Inc.(MNTA)

Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the characterization and process engineering of complex molecules. These complex molecules include proteins; polypeptides; and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company applies its technology for the development and commercialization of generic versions of complex drug products, as well as for the discovery and development of novel drugs. It offers Enoxaparin sodium injection, a generic version of Lovenox to prevent and treat deep vein thrombosis, and to support the treatment of acute coronary syndromes. The company?s products also include M356, an abbreviated new drug application under FDA review, is a generic version of Copaxone for the reduction of the frequency of relapses in patients with relapse-remitting multiple sclerosis; M118, which completed a Phase IIa clinical trial as an anticoagulant for acute coronary syndromes; and M402, a novel HSPG-based product candidate that is in preclinical development as a potential anti-cancer agent. It has collaboration agreements with Sandoz AG and Sandoz Inc. to develop and commercialize Enoxaparin sodium injection. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Dan Caplinger]

  Lately, the stock market has turned on every word from the Federal Reserve, and so this morning's comments from Federal Reserve Chairwoman Janet Yellen received a huge amount of attention from investors Monday. With Yellen offering a much more encouraging assessment of how long interest rates might remain low in order to stimulate and sustain economic growth, stocks climbed sharply, with the Dow posting triple-digit gains. Yet for MannKind (NASDAQ: MNKD  ) , Momenta Pharmaceuticals (NASDAQ: MNTA  ) , and Idera Pharmaceuticals (NASDAQ: IDRA  ) , the news today was far from good, as all three stocks suffered declines of 10% or more.

• [By Maxx Chatsko]

  Shares of biotech innovator Momenta Pharmaceuticals (NASDAQ: MNTA  ) entered into a nosedive in early June, but quickly recovered after analysts at UBS AG upgraded the stock from "neutral" to "buy." I don't put any faith in analyst projections -- and neither should you -- but I do see value in the company's technology. Momenta has developed a platform for analyzing and characterizing complex molecules that could significantly reduce R&D costs and development times of drugs in the pipeline. If you're an investor looking for a biotech company with boatloads of potential, you may be wondering about adding Momenta to your portfolio. Fool contributor Maxx Chatsko breaks down that decision for investors in the following video.

• [By Maxx Chatsko]

  Building momentum
  It may not seem too impressive on the surface, but Momenta Pharmaceuticals (NASDAQ: MNTA  ) has the makings of a game-changing biotech company. The company has developed a novel platform that greatly speeds the development and characterization of complex biological compounds. Unlike more traditional small molecules, therapeutic proteins are massive molecules whose exact chemical structure and makeup can vary from one production method to the other. Simple folds of subunits within the protein can drastically affect its efficacy and toxicity.

• [By James Brumley]

  Just bear in mind this is largely an all-or-nothing bet on the drug, though PRAN stock could rally nicely leading up to its D-Day approval.

  Momenta Pharmaceuticals (MNTA)

  Like Sagent Pharmaceuticals, Momenta Pharmaceuticals (MNTA) is a generic drugmaker. And also like Sagent, priced at $16.14 per share, MNTA stock is easily put into the cheap stocks category.

5 Best Prefered Stocks To Own Right Now: American Assets Trust Inc (AAT)

American Assets Trust, Inc. is a full-service vertically integrated and self-administered real estate investment trust (REIT). The Company owns, operates, acquires and develops retail, office, multi-family and mixed-use properties primarily in Southern California, Northern California, Oregon and Hawaii. The Company operates in four business segments: retail, office, multi-family and mixed-use. As of December 31, 2011, its portfolio consisted of 10 retail shopping centers; six office properties; a mixed-use property consisting of a 369-room all-suite hotel and a retail shopping center, and four multi-family properties. As of December 31, 2011, it owned land at five of its properties that the Company classified as held for development. On January 24, 2012, it acquired One Beach Street, consisting of approximately 97,000 rentable square feet in a renovated office building located along the Embarcadero in San Francisco�� North Waterfront District. On August 30, 2011, it sold Valencia Corporate Center.

On March 11, 2011, the Company acquired First & Main, an approximately 361,000 square foot, 16-story, office building located at 100 SW Main Street, in Portland, Oregon. On July 1, 2011, it acquired the Lloyd District Portfolio, consisting of approximately 610,000 rentable square feet on more than 16 acres located in the Lloyd District of Portland, Oregon. On September 20, 2011, it acquired the Solana Beach-Highway 101 property, consisting of approximately 1.7 acres located in Solana Beach, California. On December 14, 2011, it acquired an additional 0.2 acres adjacent to such location.

The Company is the sole general partner of American Assets Trust, L.P., a Maryland limited partnership (the Operating Partnership). The Company, as the sole general partner has control of its Operating Partnership and owned 67.8% of its Operating Partnership as of December 31, 2011. At December 31, 2011, its operating portfolio had approximately 705 leases with office and retail tenants, of which s! even expired on December 31, 2011 and 15 had not yet commenced. Its residential properties had approximately 753 leases with residential tenants at December 31, 2011, excluding Santa Fe Park RV Resort. The retail portion of its mixed-use property had approximately 64 leases with retailers.

Retail

The products for its retail segment primarily include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental. The Company�� retail properties include Carmel Country Plaza, South Bay Marketplace, Rancho Carmel Plaza, Lomas Santa Fe Plaza, Solana Beach Towne Centre, The Shops at Kalakaua, Waikele Center and Alamo Quarry Market. Its retail portfolio included 10 properties with a total of approximately three million rentable square feet available for lease as of December 31, 2011. As of December 31, 2011, these properties were 95% leased. During the year ended December 31, 2011, it signed 69 retail leases for 247,560 square feet. During 2011, the retail segment contributed 41.2%, of its total revenue.

Office

The products for its office segment primarily include rental of office space and other tenant services, including tenant reimbursements, parking and storage space rental. The Company�� office properties include Torrey Reserve, Solana Beach Corporate Centre, 160 King Street and The Landmark at One Market. Its office portfolio included six properties with a total of approximately 2.2 million rentable square feet available for lease as of December 31, 2011. As of December 31, 2011, these properties were 94.4% leased. During 2011, it signed 56 office leases for 233,213 square feet. During 2011, the office segment contributed 30.7% of its total revenue.

Multi-family

The products for its multi-family segment include rental of apartments and other tenant services. Its multi-family portfolio included three apartment properties, as well as an RV resort, with a total of 922 units! (includi! ng 122 RV spaces) available for lease as of December 31, 2011. As of December 31, 2011, these properties were 91.8% leased. Its multi-family leases, other than at its RV Resort, generally have lease terms ranging from 7 to 15 months, with a majority having 12-month lease terms. The Company�� multi-family properties include Loma Palisades, Imperial Beach Gardens, Mariner�� Point and Santa Fe Park RV Resort.

Mixed-Use Property

The products of its mixed-use segment include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental and operation of a 369-room all-suite hotel. Waikiki Beach Walk Retail and Hotel is a mixed-use property. Its mixed-use property consists of 97,000 rentable square feet of retail space and a 369-room all-suite hotel. Revenue from the mixed-use property consists of revenue earned from retail leases, and revenue earned from the hotel, which consists of room revenue, food and beverage services, parking and other guest services. As of December 31, 2011, the retail portion of the property was 99.2% leased, and during 2011, the hotel had an average occupancy of 88.4%.

Advisors' Opinion:

• [By Life Sciences Report]

  AF: Kamada Ltd. (KMDA) is a relatively unknown Israeli company that is doing very well. It is listed on the Tel Aviv Stock Exchange and the NASDAQ. It has an intravenous form of a drug for alpha-1 antitrypsin (AAT) deficiency, which causes lung and liver disease, that is partnered with Baxter International Inc. (BAX).

• [By Markus Aarnio]

  Owens Realty Mortgage's competitors include American Assets Trust (AAT), Alexandria Real Estate Equities (ARE) and Boston Properties (BXP). American Assets Trust has seen five insider buy transactions and four insider sell transactions this year. American Assets Trust has a dividend yield of 2.78%. Alexandria Real Estate Equities has seen 14 insider sell transactions this year. Alexandria Real Estate Equities has a dividend yield of 4.10%. Boston Properties has seen one insider buy transaction and four insider sell transactions this year. Boston Properties has a dividend yield of 2.43%.

• [By James E. Brumley]

  You can put American Assets Trust, Inc. (NYSE:AAT) and Park Electrochemical Corp. (NYSE:PKE) on your watchlist, if not in your portfolio. These two stocks are the best of the best among names you've probably not heard of. Just because you haven't heard of a stock, however, doesn't mean it can't dole out nice rewards. Indeed, I'm convinced the more obscure names like PKE and AAT are the market's best trading opportunities specifically because they're picks off the beaten path - the trades aren't crowded yet.